Cargando…
A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
Geranylgeranoic acid (GGA) was developed as a preventative agent against second primary hepatoma, and was reported to induce cell death in human hepatoma cells via Toll-like receptor 4 (TLR4)-mediated pyroptosis. We recently reported that GGA is enzymatically biosynthesized from mevalonic acid in hu...
Autores principales: | Shidoji, Yoshihiro, Iwao, Chieko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626837/ https://www.ncbi.nlm.nih.gov/pubmed/34869922 http://dx.doi.org/10.1016/j.bbrep.2021.101176 |
Ejemplares similares
-
TLR4-mediated pyroptosis in human hepatoma-derived HuH-7 cells induced by a branched-chain polyunsaturated fatty acid, geranylgeranoic acid
por: Yabuta, Suemi, et al.
Publicado: (2020) -
Induction of nuclear translocation of mutant cytoplasmic p53 by geranylgeranoic acid in a human hepatoma cell line
por: Iwao, Chieko, et al.
Publicado: (2014) -
Polyunsaturated Branched-Chain Fatty Acid Geranylgeranoic Acid Induces Unfolded Protein Response in Human Hepatoma Cells
por: Iwao, Chieko, et al.
Publicado: (2015) -
Enhanced Glucose Requirement in Human Hepatoma-derived HuH-7 Cells by Forced Expression of the bcl-2 Gene
por: Okamoto, Kyoko, et al.
Publicado: (2008) -
Hepatic CYP3A4 Enzyme Compensatively Maintains Endogenous Geranylgeranoic Acid Levels in MAOB-Knockout Human Hepatoma Cells
por: Tabata, Yuki, et al.
Publicado: (2022)